Willis Towers Watson Public (NASDAQ:WTW) Price Target Increased to $323.00 by Analysts at Keefe, Bruyette & Woods
Willis Towers Watson Public (NASDAQ:WTW – Free Report) had its price target lifted by Keefe, Bruyette & Woods from $320.00 to $323.00 in a research...
Raymond James Begins Coverage on Black Diamond Therapeutics (NASDAQ:BDTX)
Raymond James initiated coverage on shares of Black Diamond Therapeutics (NASDAQ:BDTX – Free Report) in a report released on Wednesday morning, MarketBeat Ratings reports. The...
The Goldman Sachs Group Increases GeneDx (NASDAQ:WGS) Price Target to $32.00
GeneDx (NASDAQ:WGS – Free Report) had its price target lifted by The Goldman Sachs Group from $28.00 to $32.00 in a research note released on...
The Future of Ferrari: 6 Exclusive UK Debuts at Goodwood
The Goodwood Festival of Speed is a haven for car aficionados. It’s a place where the past, present, and future of motoring converge. At the 2024 Goodwood Festival of...
Birks Group (NYSEAMERICAN:BGI) Research Coverage Started at StockNews.com
StockNews.com assumed coverage on shares of Birks Group (NYSEAMERICAN:BGI – Free Report) in a research report released on Wednesday morning. The brokerage issued a sell...
Analyzing Protara Therapeutics (NASDAQ:TARA) & LENZ Therapeutics (NASDAQ:LENZ)
Protara Therapeutics (NASDAQ:TARA – Get Free Report) and LENZ Therapeutics (NASDAQ:LENZ – Get Free Report) are both small-cap medical companies, but which is the better...